Jarrod Longcor
2021
In 2021, Jarrod Longcor earned a total compensation of $891.4K as Chief Operating Officer and Former Chief Business Officer at Cellectar Biosciences, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $92,409 |
|---|---|
| Option Awards | $414,000 |
| Salary | $385,037 |
| Total | $891,446 |
Longcor received $414K in option awards, accounting for 46% of the total pay in 2021.
Longcor also received $92.4K in non-equity incentive plan and $385K in salary.
Rankings
In 2021, Jarrod Longcor's compensation ranked 9,143rd out of 12,406 executives tracked by ExecPay. In other words, Longcor earned more than 26.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,143 out of 12,406 | 26th |
Division Manufacturing | 4,050 out of 5,492 | 26th |
Major group Chemicals And Allied Products | 1,783 out of 2,368 | 25th |
Industry group Drugs | 1,585 out of 2,089 | 24th |
Industry Pharmaceutical Preparations | 1,177 out of 1,536 | 23rd |
Source: SEC filing on April 29, 2022.
Longcor's colleagues
We found three more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2021.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019